Ian R. Graham

2.4k total citations
38 papers, 1.4k citations indexed

About

Ian R. Graham is a scholar working on Molecular Biology, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ian R. Graham has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 15 papers in Genetics and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ian R. Graham's work include Muscle Physiology and Disorders (16 papers), Virus-based gene therapy research (13 papers) and CRISPR and Genetic Engineering (9 papers). Ian R. Graham is often cited by papers focused on Muscle Physiology and Disorders (16 papers), Virus-based gene therapy research (13 papers) and CRISPR and Genetic Engineering (9 papers). Ian R. Graham collaborates with scholars based in United Kingdom, Netherlands and Canada. Ian R. Graham's co-authors include George Dickson, Ian C. Eperon, Alistair Chambers, Andrew D. Griffiths, Capucine Trollet, Linda Popplewell, Keith Foster, Elizabeth A. Packham, Takis Athanasopoulos and Francesco Muntoni and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Ian R. Graham

38 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ian R. Graham

Since Specialization

Citations

This map shows the geographic impact of Ian R. Graham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian R. Graham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian R. Graham more than expected).

Fields of papers citing papers by Ian R. Graham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian R. Graham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian R. Graham. The network helps show where Ian R. Graham may publish in the future.

Co-authorship network of co-authors of Ian R. Graham

This figure shows the co-authorship network connecting the top 25 collaborators of Ian R. Graham. A scholar is included among the top collaborators of Ian R. Graham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian R. Graham. Ian R. Graham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gonadotrope-specific Deletion of Dicer Results in Severely Suppressed Gonadotropins and Fertility Defects 2014 ·Journal of Biological Chemistry ·Huizhen Wang, Ian R. Graham, Richard Hastings, Sumedha Gunewardena, Michelle L. Brinkmeier, P. Michael Conn, Sally A. Camper, T. Rajendra Kumar	39
2	A risk-based approach to reducing exposure of staff to laboratory animal allergens 2014 ·Lab Animal ·(unknown), Ian R. Graham, James Bussell	9
3	Bioinformatic and Functional Optimization of Antisense Phosphorodiamidate Morpholino Oligomers (PMOs) for Therapeutic Modulation of RNA Splicing in Muscle 2010 ·Methods in molecular biology ·Linda Popplewell, Ian R. Graham, Alberto Malerba, George Dickson	9
4	Comparative analysis of antisense oligonucleotide sequences targeting exon 53 of the human DMD gene: Implications for future clinical trials 2010 ·Neuromuscular Disorders ·Linda Popplewell, C. Adkin, Virginia Arechavala‐Gomeza, Annemieke Aartsma‐Rus, C.L. de Winter, Steve D. Wilton, Jennifer E. Morgan, Francesco Muntoni, Ian R. Graham, George Dickson	33
5	Transcriptomic analysis of dystrophin RNAi knockdown reveals a central role for dystrophin in muscle differentiation and contractile apparatus organization 2010 ·BMC Genomics ·Mohammad Mahdi Ghahramani Seno, Capucine Trollet, Takis Athanasopoulos, Ian R. Graham, Pingzhao Hu, George Dickson	26
6	Adeno-associated virus serotypes 7 and 8 outperform serotype 9 in expressing atheroprotective human apoE3 from mouse skeletal muscle 2010 ·Metabolism ·Vanessa Evans, Ian R. Graham, Takis Athanasopoulos, (unknown), Christopher L. Jackson, J. Paul Simons, George Dickson, James S. Owen	4
7	RNAi-mediated knockdown of dystrophin expression in adult mice does not lead to overt muscular dystrophy pathology 2008 ·Human Molecular Genetics ·Mohammad Mahdi Ghahramani Seno, Ian R. Graham, Takis Athanasopoulos, Capucine Trollet, (unknown), M. Rufus Crompton, George Dickson	36
8	Codon and mRNA Sequence Optimization of Microdystrophin Transgenes Improves Expression and Physiological Outcome in Dystrophic mdx Mice Following AAV2/8 Gene Transfer 2008 ·Molecular Therapy ·Helen Foster, Paul Sharp, Takis Athanasopoulos, Capucine Trollet, Ian R. Graham, Keith Foster, Dominic J. Wells, George Dickson	89
9	Human Apolipoprotein E Expression from Mouse Skeletal Muscle by Electrotransfer of Nonviral DNA (Plasmid) and Pseudotyped Recombinant Adeno-Associated Virus (AAV2/7) 2008 ·Human Gene Therapy ·Vanessa Evans, Helen Foster, Ian R. Graham, Keith Foster, Takis Athanasopoulos, J. Paul Simons, George Dickson, James S. Owen	12
10	Delivery of human apolipoprotein (apo) E to liver by an [E1(-), E3(-), polymerase(-), pTP(-)] adenovirus vector containing a liver-specific promoter inhibits atherogenesis in immunocompetent apoE-deficient mice 2006 ·UCL Discovery (University College London) ·Julian D. Harris, Ian R. Graham, Andrea Amalfitano, James S. Owen, George Dickson	2
11	Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays 2004 ·The Journal of Gene Medicine ·Ian R. Graham, Vanessa J. Hill, Muthiah Manoharan, Gopal B. Inamati, George Dickson	24
12	Failure to generate atheroprotective apolipoprotein AI phenotypes using synthetic RNA/DNA oligonucleotides (chimeraplasts) 2003 ·The Journal of Gene Medicine ·Ànna Manzano, (unknown), (unknown), Manfred Ogris, Ian R. Graham, George Dickson, James S. Owen	16
13	Gene Correction of the Apolipoprotein (Apo) E2 Phenotype to Wild-type ApoE3 by in Situ Chimeraplasty 2001 ·Journal of Biological Chemistry ·Aristides D. Tagalakis, Ian R. Graham, David Riddell, J.G. Dickson, James S. Owen	70
14	Oligonucleotide-based gene correction strategies: applications to neuromuscular and cardiovascular diseases. 2001 ·PubMed ·Ian R. Graham, Stuart G. Beattie, Vanessa J. Hill, George Dickson	1
15	Rap1p is a negative regulator of the RAP1 gene 1996 ·Current Genetics ·Ian R. Graham, A. Chambers	4
16	The multifunctional transcription factors Abf1p, Rap1p and Reb1p are required for full transcriptional activation of the chromosomalPGK gene inSaccharomyces cerevisiae 1996 ·Molecular and General Genetics MGG ·Elizabeth A. Packham, Ian R. Graham, A. Chambers	18
17	Control of glycolytic gene expression in the budding yeast (Saccharomyces cerevisiae) 1995 ·Current Genetics ·Alistair Chambers, Elizabeth A. Packham, Ian R. Graham	68
18	Use of a selection technique to identify the diversity of binding sites for the yeast RAP1 transcription factor 1994 ·Nucleic Acids Research ·Ian R. Graham, Alistair Chambers	52
19	Alternative Splicing of a Human α-Tropomyosin Muscle-Specific Exon: Identification of Determining Sequences 1992 ·Molecular and Cellular Biology ·Ian R. Graham, Marion Hamshere, Ian C. Eperon	42
20	Effects of RNA secondary structure on alternative splicing of Pre-mRNA: Is folding limited to a region behind the transcribing RNA polymerase? 1988 ·Cell ·(unknown), Ian R. Graham, Andrew D. Griffiths, Ian C. Eperon	254

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact